Treatment of Uncomplicated Falciparum Malaria in Southern Vietnam: Can Chloroquine or Sulfadoxine-Pyrimethamine Be Reintroduced in Combination with Artesunate?

The effectiveness of chloroquine or sulfadoxine-pyrimethamine administered with artesunate for treating uncomplicated falciparum malaria was assessed in 2 Vietnamese provinces where the sensitivity of parasites in vitro to conventional therapies had increased with the removal of drug pressure. In th...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2003-12, Vol.37 (11), p.1461-1466
Main Authors: Huong, Nguyen Mai, Davis, Timothy M. E., Cox-Singh, Janet, Hewitt, Sean, Toan, Tran Quoc, Kim, Tran Bach, Hanh, Nguyen Thi, Phuong, Vo Nhu, Nhan, Doan Hanh, Cong, Le Dinh
Format: Article
Language:English
Subjects:
Adolescent
Adult
Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimalarials
Antimalarials - therapeutic use
Antiparasitic agents
Artemisinins
Artemisinins - therapeutic use
artesunate
Biological and medical sciences
Child
chloroquine
Chloroquine - therapeutic use
Drug Combinations
Drug Therapy, Combination
Falciparum malaria
Female
Genotype
Human protozoal diseases
Humans
Infections
Infectious diseases
Major Articles
Malaria
Malaria, Falciparum - drug therapy
Male
Medical sciences
Medical treatment failures
Parasitemia
Parasites
Parasitic diseases
Pharmacology. Drug treatments
Plasmodium falciparum
Polymerase chain reaction
Protozoal diseases
Pyrimethamine - therapeutic use
Relapse
Sesquiterpenes - therapeutic use
Sulfadoxine - therapeutic use
sulfadoxine-pyrimethamine
Treatment Outcome
Vietnam
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-3caed01cdbd61fe44f686e7cadbf15cf32fb0f2da5e09c021a6d6e17651c0b733
cites cdi_FETCH-LOGICAL-c455t-3caed01cdbd61fe44f686e7cadbf15cf32fb0f2da5e09c021a6d6e17651c0b733
container_end_page 1466
container_issue 11
container_start_page 1461
container_title Clinical infectious diseases
container_volume 37
creator Huong, Nguyen Mai
Davis, Timothy M. E.
Cox-Singh, Janet
Hewitt, Sean
Toan, Tran Quoc
Kim, Tran Bach
Hanh, Nguyen Thi
Phuong, Vo Nhu
Nhan, Doan Hanh
Cong, Le Dinh
description The effectiveness of chloroquine or sulfadoxine-pyrimethamine administered with artesunate for treating uncomplicated falciparum malaria was assessed in 2 Vietnamese provinces where the sensitivity of parasites in vitro to conventional therapies had increased with the removal of drug pressure. In the province of Dac Lac, where potential malaria exposure begins at birth, 57 subjects (mean age, 9.6 years) were randomized to receive artesunate-chloroquine (group 1) or artesunate-sulfadoxine-pyrimethamine (group 2). In the province of Binh Phuoc, 66 nonimmune workers and their relatives (mean age, 24.2 years) were similarly randomized. By day 28 of follow-up, >96% of Dac Lac patients and
doi_str_mv 10.1086/379323
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_71372031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4483721</jstor_id><oup_id>10.1086/379323</oup_id><sourcerecordid>4483721</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-3caed01cdbd61fe44f686e7cadbf15cf32fb0f2da5e09c021a6d6e17651c0b733</originalsourceid><addsrcrecordid>eNqFkt9qFDEUxgdRbK36BCLxQu9Gk8kkmfVG6mJdZcVi_1B6M5zJnLCpM8maZLB9Gl_VLLt0r0QIJCffj-9w8qUonjP6ltFGvuNqxiv-oDhkgqtSihl7mM9UNGXd8OageBLjDaWMNVQ8Lg5YLfOSzWHx5zwgpBFdIt6QC6f9uB6shoQ9OYFB2zWEaSTfYIBggVhHzvyUVhgcubSYHIzvyRwcma8GH_yvyTokPpCzaTDQ-9tclqd3wY6YVjBuxI9IfqB1Kfh-0rlJdpz7sbMOkvWO_LZpRY5DwjjlG_zwtHhkYIj4bLcfFRcnn87ni3L5_fOX-fGy1LUQqeQasKdM910vmcG6NrKRqDT0nWFCG16ZjpqqB4F0pmnFQPYSmZKCadopzo-KN1vf9WYKjKkdbdQ4DODQT7FVjKuKcvZfkM0qLkSt9qAOPsaApl3nd4Bw1zLabjJrt5ll8OXOcepG7PfYLqQMvN4BEDUMJoDTNu45wblQss7cqy3np_W_m73YMjcx-XBP1fmXqGozXbmVbUx4ey9D-NlKxZVoF1fX7fVysVxeXp22X_lfmMjEcg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19235547</pqid></control><display><type>article</type><title>Treatment of Uncomplicated Falciparum Malaria in Southern Vietnam: Can Chloroquine or Sulfadoxine-Pyrimethamine Be Reintroduced in Combination with Artesunate?</title><source>JSTOR Archival Journals and Primary Sources Collection【Remote access available】</source><source>Oxford Journals Online</source><creator>Huong, Nguyen Mai ; Davis, Timothy M. E. ; Cox-Singh, Janet ; Hewitt, Sean ; Toan, Tran Quoc ; Kim, Tran Bach ; Hanh, Nguyen Thi ; Phuong, Vo Nhu ; Nhan, Doan Hanh ; Cong, Le Dinh</creator><creatorcontrib>Huong, Nguyen Mai ; Davis, Timothy M. E. ; Cox-Singh, Janet ; Hewitt, Sean ; Toan, Tran Quoc ; Kim, Tran Bach ; Hanh, Nguyen Thi ; Phuong, Vo Nhu ; Nhan, Doan Hanh ; Cong, Le Dinh</creatorcontrib><description>The effectiveness of chloroquine or sulfadoxine-pyrimethamine administered with artesunate for treating uncomplicated falciparum malaria was assessed in 2 Vietnamese provinces where the sensitivity of parasites in vitro to conventional therapies had increased with the removal of drug pressure. In the province of Dac Lac, where potential malaria exposure begins at birth, 57 subjects (mean age, 9.6 years) were randomized to receive artesunate-chloroquine (group 1) or artesunate-sulfadoxine-pyrimethamine (group 2). In the province of Binh Phuoc, 66 nonimmune workers and their relatives (mean age, 24.2 years) were similarly randomized. By day 28 of follow-up, &gt;96% of Dac Lac patients and &lt;52% of Binh Phuoc patients in group 1 and group 2 had an in vivo response that demonstrated sensitivity to therapy. PCR-confirmed cure rates paralleled in vivo results among patients in Binh Phuoc, but PCR results identified 9 (15.7%) of the Dac Lac patients as having experienced asymptomatic, submicroscopic recrudescences. In Dac Lac, pfcrt K76T was near fixation, but infection with parasites with this mutation predicted recrudescence among group 1 patients in Binh Phuoc. Common pfdhfr mutations did not predict outcome in group 2. The successful reintroduction of conventional therapies in combination with artesunate depends on epidemiological and/or parasitological factors.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/379323</identifier><identifier>PMID: 14614668</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Adolescent ; Adult ; Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials ; Antimalarials - therapeutic use ; Antiparasitic agents ; Artemisinins ; Artemisinins - therapeutic use ; artesunate ; Biological and medical sciences ; Child ; chloroquine ; Chloroquine - therapeutic use ; Drug Combinations ; Drug Therapy, Combination ; Falciparum malaria ; Female ; Genotype ; Human protozoal diseases ; Humans ; Infections ; Infectious diseases ; Major Articles ; Malaria ; Malaria, Falciparum - drug therapy ; Male ; Medical sciences ; Medical treatment failures ; Parasitemia ; Parasites ; Parasitic diseases ; Pharmacology. Drug treatments ; Plasmodium falciparum ; Polymerase chain reaction ; Protozoal diseases ; Pyrimethamine - therapeutic use ; Relapse ; Sesquiterpenes - therapeutic use ; Sulfadoxine - therapeutic use ; sulfadoxine-pyrimethamine ; Treatment Outcome ; Vietnam</subject><ispartof>Clinical infectious diseases, 2003-12, Vol.37 (11), p.1461-1466</ispartof><rights>Copyright 2003 The Infectious Diseases Society of America</rights><rights>2003 by the Infectious Diseases Society of America 2003</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-3caed01cdbd61fe44f686e7cadbf15cf32fb0f2da5e09c021a6d6e17651c0b733</citedby><cites>FETCH-LOGICAL-c455t-3caed01cdbd61fe44f686e7cadbf15cf32fb0f2da5e09c021a6d6e17651c0b733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4483721$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4483721$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,58236,58469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15335764$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14614668$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huong, Nguyen Mai</creatorcontrib><creatorcontrib>Davis, Timothy M. E.</creatorcontrib><creatorcontrib>Cox-Singh, Janet</creatorcontrib><creatorcontrib>Hewitt, Sean</creatorcontrib><creatorcontrib>Toan, Tran Quoc</creatorcontrib><creatorcontrib>Kim, Tran Bach</creatorcontrib><creatorcontrib>Hanh, Nguyen Thi</creatorcontrib><creatorcontrib>Phuong, Vo Nhu</creatorcontrib><creatorcontrib>Nhan, Doan Hanh</creatorcontrib><creatorcontrib>Cong, Le Dinh</creatorcontrib><title>Treatment of Uncomplicated Falciparum Malaria in Southern Vietnam: Can Chloroquine or Sulfadoxine-Pyrimethamine Be Reintroduced in Combination with Artesunate?</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>The effectiveness of chloroquine or sulfadoxine-pyrimethamine administered with artesunate for treating uncomplicated falciparum malaria was assessed in 2 Vietnamese provinces where the sensitivity of parasites in vitro to conventional therapies had increased with the removal of drug pressure. In the province of Dac Lac, where potential malaria exposure begins at birth, 57 subjects (mean age, 9.6 years) were randomized to receive artesunate-chloroquine (group 1) or artesunate-sulfadoxine-pyrimethamine (group 2). In the province of Binh Phuoc, 66 nonimmune workers and their relatives (mean age, 24.2 years) were similarly randomized. By day 28 of follow-up, &gt;96% of Dac Lac patients and &lt;52% of Binh Phuoc patients in group 1 and group 2 had an in vivo response that demonstrated sensitivity to therapy. PCR-confirmed cure rates paralleled in vivo results among patients in Binh Phuoc, but PCR results identified 9 (15.7%) of the Dac Lac patients as having experienced asymptomatic, submicroscopic recrudescences. In Dac Lac, pfcrt K76T was near fixation, but infection with parasites with this mutation predicted recrudescence among group 1 patients in Binh Phuoc. Common pfdhfr mutations did not predict outcome in group 2. The successful reintroduction of conventional therapies in combination with artesunate depends on epidemiological and/or parasitological factors.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials</subject><subject>Antimalarials - therapeutic use</subject><subject>Antiparasitic agents</subject><subject>Artemisinins</subject><subject>Artemisinins - therapeutic use</subject><subject>artesunate</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>chloroquine</subject><subject>Chloroquine - therapeutic use</subject><subject>Drug Combinations</subject><subject>Drug Therapy, Combination</subject><subject>Falciparum malaria</subject><subject>Female</subject><subject>Genotype</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Major Articles</subject><subject>Malaria</subject><subject>Malaria, Falciparum - drug therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medical treatment failures</subject><subject>Parasitemia</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasmodium falciparum</subject><subject>Polymerase chain reaction</subject><subject>Protozoal diseases</subject><subject>Pyrimethamine - therapeutic use</subject><subject>Relapse</subject><subject>Sesquiterpenes - therapeutic use</subject><subject>Sulfadoxine - therapeutic use</subject><subject>sulfadoxine-pyrimethamine</subject><subject>Treatment Outcome</subject><subject>Vietnam</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkt9qFDEUxgdRbK36BCLxQu9Gk8kkmfVG6mJdZcVi_1B6M5zJnLCpM8maZLB9Gl_VLLt0r0QIJCffj-9w8qUonjP6ltFGvuNqxiv-oDhkgqtSihl7mM9UNGXd8OageBLjDaWMNVQ8Lg5YLfOSzWHx5zwgpBFdIt6QC6f9uB6shoQ9OYFB2zWEaSTfYIBggVhHzvyUVhgcubSYHIzvyRwcma8GH_yvyTokPpCzaTDQ-9tclqd3wY6YVjBuxI9IfqB1Kfh-0rlJdpz7sbMOkvWO_LZpRY5DwjjlG_zwtHhkYIj4bLcfFRcnn87ni3L5_fOX-fGy1LUQqeQasKdM910vmcG6NrKRqDT0nWFCG16ZjpqqB4F0pmnFQPYSmZKCadopzo-KN1vf9WYKjKkdbdQ4DODQT7FVjKuKcvZfkM0qLkSt9qAOPsaApl3nd4Bw1zLabjJrt5ll8OXOcepG7PfYLqQMvN4BEDUMJoDTNu45wblQss7cqy3np_W_m73YMjcx-XBP1fmXqGozXbmVbUx4ey9D-NlKxZVoF1fX7fVysVxeXp22X_lfmMjEcg</recordid><startdate>20031201</startdate><enddate>20031201</enddate><creator>Huong, Nguyen Mai</creator><creator>Davis, Timothy M. E.</creator><creator>Cox-Singh, Janet</creator><creator>Hewitt, Sean</creator><creator>Toan, Tran Quoc</creator><creator>Kim, Tran Bach</creator><creator>Hanh, Nguyen Thi</creator><creator>Phuong, Vo Nhu</creator><creator>Nhan, Doan Hanh</creator><creator>Cong, Le Dinh</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20031201</creationdate><title>Treatment of Uncomplicated Falciparum Malaria in Southern Vietnam: Can Chloroquine or Sulfadoxine-Pyrimethamine Be Reintroduced in Combination with Artesunate?</title><author>Huong, Nguyen Mai ; Davis, Timothy M. E. ; Cox-Singh, Janet ; Hewitt, Sean ; Toan, Tran Quoc ; Kim, Tran Bach ; Hanh, Nguyen Thi ; Phuong, Vo Nhu ; Nhan, Doan Hanh ; Cong, Le Dinh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-3caed01cdbd61fe44f686e7cadbf15cf32fb0f2da5e09c021a6d6e17651c0b733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials</topic><topic>Antimalarials - therapeutic use</topic><topic>Antiparasitic agents</topic><topic>Artemisinins</topic><topic>Artemisinins - therapeutic use</topic><topic>artesunate</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>chloroquine</topic><topic>Chloroquine - therapeutic use</topic><topic>Drug Combinations</topic><topic>Drug Therapy, Combination</topic><topic>Falciparum malaria</topic><topic>Female</topic><topic>Genotype</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Major Articles</topic><topic>Malaria</topic><topic>Malaria, Falciparum - drug therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medical treatment failures</topic><topic>Parasitemia</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasmodium falciparum</topic><topic>Polymerase chain reaction</topic><topic>Protozoal diseases</topic><topic>Pyrimethamine - therapeutic use</topic><topic>Relapse</topic><topic>Sesquiterpenes - therapeutic use</topic><topic>Sulfadoxine - therapeutic use</topic><topic>sulfadoxine-pyrimethamine</topic><topic>Treatment Outcome</topic><topic>Vietnam</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huong, Nguyen Mai</creatorcontrib><creatorcontrib>Davis, Timothy M. E.</creatorcontrib><creatorcontrib>Cox-Singh, Janet</creatorcontrib><creatorcontrib>Hewitt, Sean</creatorcontrib><creatorcontrib>Toan, Tran Quoc</creatorcontrib><creatorcontrib>Kim, Tran Bach</creatorcontrib><creatorcontrib>Hanh, Nguyen Thi</creatorcontrib><creatorcontrib>Phuong, Vo Nhu</creatorcontrib><creatorcontrib>Nhan, Doan Hanh</creatorcontrib><creatorcontrib>Cong, Le Dinh</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huong, Nguyen Mai</au><au>Davis, Timothy M. E.</au><au>Cox-Singh, Janet</au><au>Hewitt, Sean</au><au>Toan, Tran Quoc</au><au>Kim, Tran Bach</au><au>Hanh, Nguyen Thi</au><au>Phuong, Vo Nhu</au><au>Nhan, Doan Hanh</au><au>Cong, Le Dinh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Uncomplicated Falciparum Malaria in Southern Vietnam: Can Chloroquine or Sulfadoxine-Pyrimethamine Be Reintroduced in Combination with Artesunate?</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2003-12-01</date><risdate>2003</risdate><volume>37</volume><issue>11</issue><spage>1461</spage><epage>1466</epage><pages>1461-1466</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>The effectiveness of chloroquine or sulfadoxine-pyrimethamine administered with artesunate for treating uncomplicated falciparum malaria was assessed in 2 Vietnamese provinces where the sensitivity of parasites in vitro to conventional therapies had increased with the removal of drug pressure. In the province of Dac Lac, where potential malaria exposure begins at birth, 57 subjects (mean age, 9.6 years) were randomized to receive artesunate-chloroquine (group 1) or artesunate-sulfadoxine-pyrimethamine (group 2). In the province of Binh Phuoc, 66 nonimmune workers and their relatives (mean age, 24.2 years) were similarly randomized. By day 28 of follow-up, &gt;96% of Dac Lac patients and &lt;52% of Binh Phuoc patients in group 1 and group 2 had an in vivo response that demonstrated sensitivity to therapy. PCR-confirmed cure rates paralleled in vivo results among patients in Binh Phuoc, but PCR results identified 9 (15.7%) of the Dac Lac patients as having experienced asymptomatic, submicroscopic recrudescences. In Dac Lac, pfcrt K76T was near fixation, but infection with parasites with this mutation predicted recrudescence among group 1 patients in Binh Phuoc. Common pfdhfr mutations did not predict outcome in group 2. The successful reintroduction of conventional therapies in combination with artesunate depends on epidemiological and/or parasitological factors.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>14614668</pmid><doi>10.1086/379323</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2003-12, Vol.37 (11), p.1461-1466
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_71372031
source JSTOR Archival Journals and Primary Sources Collection【Remote access available】; Oxford Journals Online
subjects Adolescent
Adult
Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimalarials
Antimalarials - therapeutic use
Antiparasitic agents
Artemisinins
Artemisinins - therapeutic use
artesunate
Biological and medical sciences
Child
chloroquine
Chloroquine - therapeutic use
Drug Combinations
Drug Therapy, Combination
Falciparum malaria
Female
Genotype
Human protozoal diseases
Humans
Infections
Infectious diseases
Major Articles
Malaria
Malaria, Falciparum - drug therapy
Male
Medical sciences
Medical treatment failures
Parasitemia
Parasites
Parasitic diseases
Pharmacology. Drug treatments
Plasmodium falciparum
Polymerase chain reaction
Protozoal diseases
Pyrimethamine - therapeutic use
Relapse
Sesquiterpenes - therapeutic use
Sulfadoxine - therapeutic use
sulfadoxine-pyrimethamine
Treatment Outcome
Vietnam
title Treatment of Uncomplicated Falciparum Malaria in Southern Vietnam: Can Chloroquine or Sulfadoxine-Pyrimethamine Be Reintroduced in Combination with Artesunate?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A40%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Uncomplicated%20Falciparum%20Malaria%20in%20Southern%20Vietnam:%20Can%20Chloroquine%20or%20Sulfadoxine-Pyrimethamine%20Be%20Reintroduced%20in%20Combination%20with%20Artesunate?&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Huong,%20Nguyen%20Mai&rft.date=2003-12-01&rft.volume=37&rft.issue=11&rft.spage=1461&rft.epage=1466&rft.pages=1461-1466&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/379323&rft_dat=%3Cjstor_proqu%3E4483721%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-3caed01cdbd61fe44f686e7cadbf15cf32fb0f2da5e09c021a6d6e17651c0b733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19235547&rft_id=info:pmid/14614668&rft_jstor_id=4483721&rft_oup_id=10.1086/379323&rfr_iscdi=true